Treatment of cultured cells with an angiotensin converting enzyme inhibitor (ACEi) or in combination with the anti‐fibrotic peptide AcSDKP prevented TGF‐β‐induced downregulation of miR‐29 and miR‐let‐7 in ECs, inhibited EndMT and impeded renal fibrosis progression.55 The gene discussed is TGFB1; the disease is renal fibrosis.